| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Encore Unlimited is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BGHS is a state-licensed, non-profit behavioral healthcare provider located in Ansonia, CT, serving the citizens of the Lower Naugatuck Valley and surrounding communities. One out of every five Americans suffers from some form of mental illness. Each
Cook Children's Medical Center - Cook Children's Community Clinics is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Instrument Development Laboratories is a San Leandro, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.